WallStreetZenWallStreetZen

NYSEMKT: RMED
Ra Medical Systems Inc Stock

Overview
EarningsDividendOwnership
$1.52+0.08 (+5.56%)
Updated Mar 27, 2023
RMED Price
$1.52
Fair Value Price
N/A
Market Cap
$3.29M
52 Week Low
$1.30
52 Week High
$29.50
P/E
-0.02x
P/B
0.26x
P/S
344.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.00k
Earnings
-$26.99M
Gross Margin
-2,573.7%
Operating Margin
-142,047.37%
Profit Margin
-142,068.4%
Debt to Equity
0.4
Operating Cash Flow
-$25M
Beta
0.7
Next Earnings
May 15, 2023
Ex-Dividend
N/A
Next Dividend
N/A

RMED Overview

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Zen Score

–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RMED scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RMED is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RMED is good value based on its book value relative to its share price (0.26x), compared to the US Medical Devices industry average (3.79x)
P/B vs Industry Valuation
RMED is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RMED due diligence checks available for Premium users.

Be the first to know about important RMED news, forecast changes, insider trades & much more!

RMED News

Valuation

RMED price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.02x
Industry
90.44x
Market
21.44x

RMED price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.26x
Industry
3.79x
RMED is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RMED's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.8M
Profit Margin
0%
RMED's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
RMED's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.5M
Liabilities
$5.0M
Debt to equity
0.4
RMED's short-term assets ($15.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RMED's short-term assets ($15.54M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RMED's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.0M
Investing
$0.0
Financing
$7.5M
RMED's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RMED vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
RMED$3.29M+5.56%-0.02x0.26x
THMO$3.45M-12.34%-0.11x0.68x
BBLG$3.49M-5.00%-2.28x0.79x
INBS$2.71M-3.28%-0.44x0.26x
BIOL$2.67M+2.19%-0.10x0.19x
View Top Medical Device Stocks

Ra Medical Systems Stock FAQ

What is Ra Medical Systems's quote symbol?

NYSEMKT: RMED) Ra Medical Systems trades on the NYSEMKT under the ticker symbol RMED. Ra Medical Systems stock quotes can also be displayed as NYSEMKT: RMED.

If you're new to stock investing, here's how to buy Ra Medical Systems stock.

What is the 52 week high and low for Ra Medical Systems (NYSEMKT: RMED)?

(NYSEMKT: RMED) Ra Medical Systems's 52-week high was $29.50, and its 52-week low was $1.30. It is currently -94.85% from its 52-week high and 16.92% from its 52-week low.

How much is Ra Medical Systems stock worth today?

(NYSEMKT: RMED) Ra Medical Systems currently has 2,161,406 outstanding shares. With Ra Medical Systems stock trading at $1.52 per share, the total value of Ra Medical Systems stock (market capitalization) is $3.29M.

Ra Medical Systems stock was originally listed at a price of $25,000.00 in Sep 27, 2018. If you had invested in Ra Medical Systems stock at $25,000.00, your return over the last 4 years would have been -99.99%, for an annualized return of -91.17% (not including any dividends or dividend reinvestments).

How much is Ra Medical Systems's stock price per share?

(NYSEMKT: RMED) Ra Medical Systems stock price per share is $1.52 today (as of Mar 27, 2023).

What is Ra Medical Systems's Market Cap?

(NYSEMKT: RMED) Ra Medical Systems's market cap is $3.29M, as of Mar 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ra Medical Systems's market cap is calculated by multiplying RMED's current stock price of $1.52 by RMED's total outstanding shares of 2,161,406.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.